NeuroTraX-AI targets the blood-brain barrier, a central hurdle in brain medicine and drug safety, as U.S. regulators ...
Reactions to low rates of molecular testing for patients with non-small cell lung cancer in community settings. Charu Aggarwal, M.D., MPH: Recent data show that there are many challenges. We saw ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results